Razadyne/Reminyl (Alzheimer’s Disease):市場予測と分析(~2022)...市場調査レポートについてご紹介

【英文タイトル】Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022

Razadyne/Reminyl (Alzheimer’s Disease):市場予測と分析(~2022) (Code:GDATA403162278)


Razadyne/Reminyl (Alzheimer’s Disease) – Forecast and Market Analysis to 2022


GlobalData has released its new PharmaPoint Drug Evaluation report, “Razadyne/Reminyl (Alzheimer’s Disease) – Forecast and Market Analysis to 2022”. There are no long-term effective therapies for Alzheimer’s Disease (AD), so this remains at the top of the list for unmet needs. While physicians agree that symptomatic therapies are relatively safe and effective, these therapies are still lacking because of they cannot maintain their effects and lack mechanisms that alter the course of the disease.

Razadyne (also known as Reminyl) is a reversible, competitive AChEI indicated for the treatment of mild to moderate AD. The exact MOA of galantamine is not known; however, it is thought to exert its effects by enhancing cholinergic function as a result of an increase in the concentration of ACh through reversible inhibition of hydrolysis by cholinesterase.


– Overview of AD, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape._x000D_
– Detailed information on Razadyne / Reminyl including product description, safety and efficacy profiles as well as a SWOT analysis._x000D_
– Sales forecast for Razadyne / Reminyl for the top eight countries from 2012 to 2022._x000D_
– Sales information covered for France, Germany, Italy, Spain, the UK, Japan, China and India.

Reasons to buy

– Understand and capitalize by identifying products that are most likely to ensure a robust return_x000D_
– Stay ahead of the competition by understanding the changing competitive landscape for AD_x000D_
– Effectively plan your M&A and partnership strategies by identifying drugs with the most promising sales potential_x000D_
– Make more informed business decisions from insightful and in-depth analysis of Razadyne / Reminyl performance_x000D_
– Obtain sales forecast for Razadyne / Reminyl from 2012-2022 in top eight countries (France, Germany, Italy, Spain, the UK, Japan, China and India)






1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
3 Disease Overview 11
3.1 Etiology and Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology 15
3.2 Symptoms 27
4 Disease Management 29
4.1 Diagnosis 29
4.1.1 Probable Alzheimer’s Disease Dementia 30
4.1.2 Possible AD Dementia 31
4.1.3 Probable AD Dementia with Evidence of AD Pathophysiological Process 31
4.1.4 Possible Alzheimer’s Dementia with Evidence of the Alzheimer’s Disease Pathophysiological Process 32
4.1.5 Preclinical AD 32
4.1.6 Mild Cognitive Impairment 33
4.2 Treatment Overview 35
5 Competitive Assessment 38
5.1 Overview 38
5.2 Strategic Competitor Assessment 38
6 Razadyne/ Reminyl 41
6.1 Overview 41
6.2 Efficacy 42
6.3 Safety 44
6.4 SWOT Analysis 44
6.5 Forecast 45
7 Appendix 46
7.1 Bibliography 46
7.2 Abbreviations 51
7.3 Methodology 54
7.4 Forecasting Methodology 54
7.4.1 Diagnosed AD patients 55
7.4.2 Percent Drug-treated Patients 56
7.4.3 General Pricing Assumptions 56
7.4.4 Individual Drug Assumptions 58
7.4.5 Generic Erosion 58
7.5 Physicians and Specialists Included in this Study 59
7.6 About the Authors 60
7.6.1 Author 60
7.6.2 Global Head of Healthcare 61
7.7 About GlobalData 62
7.8 Disclaimer 62






■ タイトル:Razadyne/Reminyl (Alzheimer’s Disease):市場予測と分析(~2022)
■ 英文:Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022
■ 発行日:2013年9月30日
■ 調査会社:GlobalData
■ 商品コード:GDATA403162278
■ 調査対象地域:グローバル

Razadyne/Reminyl (Alzheimer’s Disease):市場予測と分析(~2022) (Razadyne/Reminyl (Alzheimer’s Disease) - Forecast and Market Analysis to 2022 / GDATA403162278)

  • 世界のメイクアップ市場動向(2014年4月):ニュース・イベント
    Synopsis Using this report, marketers will effectively gain an insight into the latest happenings in the global make-up market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the global make-up market on a monthly basis. Scope The report provides a review of the latest news and key events in the global make-u …
  • AGL Energy Limited:発電所及びSWOT分析2013
    AGL Energy Limited - Power Plants and SWOT Analysis, 2013 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services. Scope - Major Power Plants (assets) - summarized and …
  • DevOpsツールの世界市場2015-2019
    About DevOps tools The concept of DevOps can be demonstrated as an approach to software development that involves better collaboration among development and operational functions to reduce cycle time from the development inception to release. This is posssible only by continuous participation of operations team and developers right from the stage of design to development and production support. Th …
  • 世界における小型自動車用OE(メーカー純正部品)タイヤ市場動向と予測(~2029)
    This latest just-auto report edition offers a global review of the OE tyres sector, its suppliers, top markets, technologies and market forecasts. This global market study offers: Automotive OE tyres market size estimates Latest technologies and trends Market share data tables Exclusive interviews with major companies Profiles of the major players including their strategies and prospects Market si …
  • はしか検査の世界市場2015
    The report presents a detailed analysis of the Measles diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Measles definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - …
  • 世界の自己免疫疾患用装置開発動向:医療機器パイプライン分析2015
    Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Auto-Immune Diseases - Medical Devices Pipeline Assessment, 2015" provides an overview of Auto-Immune Diseases currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of developm …
  • 携帯型ラベルプリンターの世界市場2015-2019
    Technavio market research analyst predicts the global handheld label printer market to grow at a CAGR of 7% during the forecast period. The need for proximal and immediate access to label printers by the mobile workforce, globally, is driving the growth of this market. Handheld label printers are lightweight and can work without being connected to a computer, providing the much-needed flexibility …
  • 自己免疫疾患用薬の世界市場2016-2020
    About Autoimmune Diseases Drugs Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies, causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidney …
  • グローバルにおけるHDTV市場(2014-2018)
    About HDTV The HDTV is a next generation television equipped with better resolution and high quality display. It is based on a digital broadcasting format that transmits a widescreen display, enlarged and clear image, better sound quality and projections. According to the EIA, high definition in TV can be measured by the resolution of the picture or the number of horizontal and vertical lines scan …
  • 世界のキラル技術市場動向(2012-2016)
    TechNavio’s analysts forecast the Global Chiral Technology market to grow at a CAGR of 6.6 percent over the period 2012-2016. One of the key factors contributing to this market growth is favorable government regulations for chiral technology. The Global Chiral Technology market has also been witnessing increasing reliance on generic approaches. However, the slow commercialization of chiral technol …
  • 世界の商用航空機市場動向2013-2023:市場規模及び成長要因
    The global commercial aircraft sector is expected to experience slow and stable growth during the forecast period. According to Boeing’s estimates, airline companies around the world are expected to procure approximately 34000 airplanes during 2011-2031.
  • 機内エンターテイメント(IFE)の世界市場2016-2020
    About In-Flight Entertainment Globally, airlines are seeking to retrofit their aircraft with the latest technological upgrades for cost-effective operational efficiency and increased life span. Different upgrading, retrofitting, and modernizing functions are performed on avionics, IFEs, and aircraft cabin interiors (food storage equipment, seats, galley, windshields and lavatory, windows, and aero …
  • 排気浄化触媒の世界市場:パラジウム触媒、プラチナ触媒、ロジウム触媒
    The emission control catalyst market was estimated around $8.0 billion in 2013, with the high share of around 60% held by the Europe and Asia-Pacific together. The global emission control catalyst market by value is projected to grow at a CAGR of 10.4% from 2014 to 2019. The high growth is forecasted to be in the Europe due to the stringent emission control standards in the region. North America i …
  • スマートグリッド市場レビュー:February 2013
    Smart Grid Review - February 2013 Summary GlobalData announces the release of its monthly smart grid newsletter for February 2013 from the Smart Grid eTrack. The newsletter provides update on the global developments related to smart grid deployment across the globe during the month of January 2013. Scope - Market prospect for companies providing smart grid systems - Key product launch in power gri …
  • 睡眠時無呼吸症治療装置の世界市場予測(~2021):製品別、治療別(CPAP、APAP、BPAP、マスク、口腔装置(下顎前方固定装置)、診断別、需要先別
    The sleep apnea devices market is projected to reach USD 6.70 Billion by 2021 from USD 4.59 Billion in 2016, growing at a CAGR of 7.8% during the forecast period. Factors such as growing awareness regarding the ill effects of sleep apnea, growing usage of oral appliances for sleep apnea treatment, and the large pool of undiagnosed and untreated sleep apnea patients are driving the growth of the ma …